Integrated Biobanking Shared Resource
综合生物样本库共享资源
基本信息
- 批准号:10239119
- 负责人:
- 金额:$ 28.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAnimal ModelAnimalsBasic ScienceBiological AssayBloodCancer CenterCancer Center Support GrantCancer ModelClinicalClinical DataCollaborationsCollectionComprehensive Cancer CenterConsentConsultationsDNADataDatabasesDevelopmentEnrollmentEnsureEpidemiologyEtiologyFormalinFrozen SectionsFundingFutureGenomicsHistologyHistopathologyHospitalsHumanHuman ResourcesImage AnalysisImmunohistochemistryInformed ConsentInvestigationMaintenanceMalignant NeoplasmsMedicineMetagenomicsNational Cancer InstituteNormal tissue morphologyParaffin EmbeddingPathologicPathologistPathologyPeripheral Blood Mononuclear CellPlayPopulation ResearchPopulation SciencesPreventionProteomicsQuestionnairesResearchResearch ActivityResearch PersonnelResource SharingResourcesRisk FactorsRoleScanningScienceSecureServicesSlideSpecimenStainsStructureTechnologyTissue EmbeddingTissue MicroarrayTissuesTrainingTranslational ResearchUrineVenous blood samplinganticancer researchbasebiobankcancer specimen resourcecancer therapycell preparationclinical carecollegeepidemiologic dataexperiencefollow-uphistological stainshuman tissuein vivolaser capture microdissectionmetabolomicsmicrobiomemouse modelmultidisciplinarymultiplexed imagingoperationoptimal treatmentspatient derived xenograft modelprogramstissue processingtranscriptomicstranslational scientisttumor
项目摘要
PROJECT SUMMARY: Integrated Biobanking Shared Resource (IBSR)
The purpose of the Integrated Biobanking Shared Resource is to provide access to biospecimens by
coordinated general and targeted biospecimen acquisition along with relevant expertise and technical
resources to enhance basic, translational and clinical cancer biospecimen-based research activities at the Dan
L. Duncan Comprehensive Cancer Center. Access to such resources is critical for biospecimen-based cancer
investigations. This Shared Resource (SR) is a merger of the prior Human Tissue Acquisition and Pathology
(HTAP) and the Population Sciences Biorepository (PSB) SRs into a single Integrated Biobanking SR (IBSR).
This is a natural outgrowth of the close working relationship of the HTAP and PSB SRs over many years.
Merger of HTAP and PSB SRs will allow us to further integrate our operations within a common management
structure. The Shared Resource personnel have extensive experience in pathology, epidemiology,
biospecimen acquisition and processing, bank maintenance and distribution. In addition, personnel are trained
in the various technical services offered including peripheral blood mononuclear cell preparation, DNA
extraction, routine histology services, frozen sections, tissue microarray construction, immunohistochemistry,
tissue microarray scanning, and multiplex image analysis. We also provide pathology consultation by expert
pathologists for both human tissue specimens and mouse models, and risk factor questionnaire development
and collection.
项目总结:综合生物库共享资源(IBSR)
综合生物库共享资源的目的是通过以下方式提供对生物样本的访问
协调一般和有针对性的生物标本采集,沿着相关专业知识和技术
资源,以加强基础,转化和临床癌症生物医学为基础的研究活动,在丹
L.邓肯综合癌症中心。获得这些资源对于生物制药癌症至关重要
调查事务所此共享资源(SR)是先前的人体组织采集和病理学的合并
(HTAP)和人口科学生物储存库(PSB)SR合并为单个综合生物库SR(IBSR)。
这是HTAP和PSB员工代表多年来密切工作关系的自然结果。
HTAP和PSB SR的合并将使我们能够在共同的管理中进一步整合我们的业务
结构共享资源人员在病理学,流行病学,
生物标本的获取和处理、库的维护和分发。此外,还对人员进行培训,
在提供的各种技术服务中,包括外周血单核细胞制备、DNA
提取,常规组织学服务,冷冻切片,组织微阵列构建,免疫组织化学,
组织微阵列扫描和多重图像分析。我们还提供专家病理咨询
病理学家为人类组织标本和小鼠模型,并制定风险因素问卷
和收藏。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael M Ittmann其他文献
Michael M Ittmann的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael M Ittmann', 18)}}的其他基金
Highly specific targeting of the TMPRSS2/ERG fusion gene in prostate cancer
TMPRSS2/ERG 融合基因在前列腺癌中的高度特异性靶向
- 批准号:
8732393 - 财政年份:2014
- 资助金额:
$ 28.8万 - 项目类别:
Highly specific targeting of the TMPRSS2/ERG fusion gene in prostate cancer
TMPRSS2/ERG 融合基因在前列腺癌中的高度特异性靶向
- 批准号:
9487872 - 财政年份:2014
- 资助金额:
$ 28.8万 - 项目类别:
A novel oncogenic axis in African American prostate cancer
非裔美国人前列腺癌的新致癌轴
- 批准号:
10158403 - 财政年份:2014
- 资助金额:
$ 28.8万 - 项目类别:
A novel oncogenic axis in African American prostate cancer
非裔美国人前列腺癌的新致癌轴
- 批准号:
10455444 - 财政年份:2014
- 资助金额:
$ 28.8万 - 项目类别:
Mechanisms of Cytokine Induced Lower Urinary Track Pathology
细胞因子诱导下尿路病理学机制
- 批准号:
8566162 - 财政年份:2012
- 资助金额:
$ 28.8万 - 项目类别:
Mechanisms of Cytokine Induced Lower Urinary Track Pathology
细胞因子诱导下尿路病理学机制
- 批准号:
8445575 - 财政年份:2012
- 资助金额:
$ 28.8万 - 项目类别:
Mechanisms of Cytokine Induced Lower Urinary Track Pathology
细胞因子诱导下尿路病理学机制
- 批准号:
8549230 - 财政年份:2012
- 资助金额:
$ 28.8万 - 项目类别:
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
FGFR1 信号在不同细胞谱系中在前列腺癌进展中的作用
- 批准号:
8137691 - 财政年份:2009
- 资助金额:
$ 28.8万 - 项目类别:
Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion
FGFR1 信号在不同细胞谱系中在前列腺癌进展中的作用
- 批准号:
8334481 - 财政年份:2009
- 资助金额:
$ 28.8万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 28.8万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 28.8万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 28.8万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 28.8万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 28.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 28.8万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 28.8万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 28.8万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 28.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 28.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists